For research use only. Not for therapeutic Use.
Dinobuton(Cat No.:I026219)is a central nervous system stimulant and nootropic agent, primarily used in some countries to treat conditions such as attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by modulating neurotransmitter systems, particularly dopamine and norepinephrine, which help regulate attention, wakefulness, and cognitive function. Dinobuton has been studied for its potential cognitive-enhancing effects, such as improving memory and concentration. However, its use is limited due to concerns about side effects, dependency, and its long-term safety. As a result, it is not widely prescribed and is subject to varying regulatory controls across regions.
Catalog Number | I026219 |
CAS Number | 973-21-7 |
Synonyms | Kasebon; Sytasol; Talan |
Molecular Formula | C14H18N2O7 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | (2-butan-2-yl-4,6-dinitrophenyl) propan-2-yl carbonate |
InChI | InChI=1S/C14H18N2O7/c1-5-9(4)11-6-10(15(18)19)7-12(16(20)21)13(11)23-14(17)22-8(2)3/h6-9H,5H2,1-4H3 |
InChIKey | HDWLUGYOLUHEMN-UHFFFAOYSA-N |
SMILES | CCC(C)C1=C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])OC(=O)OC(C)C |
Reference | 1: Trinus FP, Braver-Chernobul’skaia BS, Luĭk AI, Boldeskul AE, Velichko AN. [Changes in the secondary and tertiary structure of serum albumin in interactions with ligands of various structures]. Vopr Med Khim. 1984 Jul-Aug;30(4):48-50. Russian. PubMed PMID: 6239449. |